Effectiveness and safety of narlaprevir in real clinical practice of chronic hepatitis C by V. V. Basina, S. E. Kalach, N. V. Tyurenkova, M. E. Semenova, E. Yu. Yushina, E. G. Gordievskaya, R. A. Ganchenko, Е. V. Esaulenko

Get full text

Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg by D. A. Gusev, K. V. Zhdanov, K. V. Kozlov, T. N. Vinogradova, M. Yu. Kopot, V. S. Sukachev, S. S. Zhabrov, S. N. Kizhlo, S. Yu. Romanova, V. B. Musatov, N. V. Tyurenkova, Yu. A. Vlasova, E. Yu. Kolpashchikova, P. N. Fedorov, P. V. Minin, T. S. Korneeva

Get full text